Metabolomics and allergy: Opening Pandora’s box
- 1 March 2020
- journal article
- editorial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (3) , 782-784
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthmaJournal of Allergy and Clinical Immunology, 2020
- ORMDL3 and allergic asthma: From physiology to pathologyJournal of Allergy and Clinical Immunology, 2019
- Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision MedicineFrontiers in Immunology, 2018
- Multi‐omics analysis points to altered platelet functions in severe food‐associated respiratory allergyAllergy, 2018
- Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergyJournal of Allergy and Clinical Immunology, 2018
- Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activationJournal of Allergy and Clinical Immunology, 2014
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelinJournal of Allergy and Clinical Immunology, 2011
- Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestineProceedings of the National Academy of Sciences, 2010
- Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivityNature Medicine, 2003